Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H

Arch Virol. 1991;118(3-4):179-88. doi: 10.1007/BF01314028.

Abstract

The reverse transcriptase/RNase H of HIV-1 is composed of a p66/p51 heterodimer when analyzed from virus particles. A recombinant reverse transcriptase (RT)/RNase H which after purification consisted mainly of p66 was analyzed as substrate of the purified recombinant HIV-1 protease p9 in vitro. The p66 protein if treated with the protease is processed to a stable p66/p51 heterodimer. A p15 protein is a prominent cleavage product which was identified as the carboxyterminal portion of p66 by means of a monoclonal antibody. It exhibits RNase H activity when tested by activated gel analysis. Presence of SDS during the incubation allowed complete degradation of p66 depending on the conditions, which indicates that conformation of a substrate is relevant for cleavage by the HIV-1 protease. A synthetic heptapeptide AET-FYVD derived from the region between RT and RNase H is cleaved efficiently in vitro by the HIV-1 protease at the F'Y junction, and may mimick a natural cleavage site. P66/p51 heterodimers exhibit higher RT and RNase H activities than p66 when renatured from polyacrylamide gels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, High Pressure Liquid
  • Endoribonucleases / metabolism*
  • Gene Products, pol / metabolism*
  • HIV Protease / metabolism
  • HIV-1 / enzymology*
  • Oligopeptides / chemical synthesis
  • Oligopeptides / metabolism
  • RNA-Directed DNA Polymerase / metabolism*
  • Ribonuclease H
  • Sodium Dodecyl Sulfate / pharmacology

Substances

  • Gene Products, pol
  • Oligopeptides
  • Sodium Dodecyl Sulfate
  • RNA-Directed DNA Polymerase
  • Endoribonucleases
  • Ribonuclease H
  • HIV Protease